Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 279

1.

Experimental systemic murine aspergillosis: treatment with polyene and caspofungin combination and G-CSF.

Sionov E, Mendlovic S, Segal E.

J Antimicrob Chemother. 2005 Sep;56(3):594-7. Epub 2005 Jul 8.

PMID:
16006446
2.

Efficacy of amphotericin B or amphotericin B-intralipid in combination with caspofungin against experimental aspergillosis.

Sionov E, Mendlovic S, Segal E.

J Infect. 2006 Aug;53(2):131-9. Epub 2005 Dec 19.

PMID:
16360214
4.

Caspofungin: antifungal activity in vitro, pharmacokinetics, and effects on fungal load and animal survival in neutropenic rats with invasive pulmonary aspergillosis.

van Vianen W, de Marie S, ten Kate MT, Mathot RA, Bakker-Woudenberg IA.

J Antimicrob Chemother. 2006 Apr;57(4):732-40. Epub 2006 Feb 7.

PMID:
16464895
5.

Polyene and cytokine treatment of experimental aspergillosis.

Sionov E, Segal E.

FEMS Immunol Med Microbiol. 2003 Dec 5;39(3):221-7.

6.

Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate.

Bowman JC, Abruzzo GK, Anderson JW, Flattery AM, Gill CJ, Pikounis VB, Schmatz DM, Liberator PA, Douglas CM.

Antimicrob Agents Chemother. 2001 Dec;45(12):3474-81.

7.
8.

Differences in efficacy and cytokine profiles following echinocandin or liposomal amphotericin B monotherapy or combination therapy for murine pulmonary or systemic Aspergillus flavus infections.

Olson JA, Schwartz J, Hahka D, George A, Proffitt RT, Adler-Moore JP.

Antimicrob Agents Chemother. 2012 Jan;56(1):218-30. doi: 10.1128/AAC.00607-11. Epub 2011 Oct 3.

9.

Combination therapy with micafungin and amphotericin B for invasive pulmonary aspergillosis in an immunocompromised mouse model.

Nagasaki Y, Eriguchi Y, Uchida Y, Miyake N, Maehara Y, Kadowaki M, Harada M, Akashi K, Shimono N.

J Antimicrob Chemother. 2009 Aug;64(2):379-82. doi: 10.1093/jac/dkp175. Epub 2009 May 22.

PMID:
19465436
10.

Effect of amphotericin B and micafungin combination on survival, histopathology, and fungal burden in experimental aspergillosis in the p47phox-/- mouse model of chronic granulomatous disease.

Dennis CG, Greco WR, Brun Y, Youn R, Slocum HK, Bernacki RJ, Lewis R, Wiederhold N, Holland SM, Petraitiene R, Walsh TJ, Segal BH.

Antimicrob Agents Chemother. 2006 Feb;50(2):422-7.

11.

Efficacy of Abelcet and caspofungin, alone or in combination, against CNS aspergillosis in a murine model.

Imai J, Singh G, Fernandez B, Clemons KV, Stevens DA.

J Antimicrob Chemother. 2005 Jul;56(1):166-71. Epub 2005 May 25.

PMID:
15917284
12.

Efficacy of LY303366 against amphotericin B-susceptible and -resistant Aspergillus fumigatus in a murine model of invasive aspergillosis.

Verweij PE, Oakley KL, Morrissey J, Morrissey G, Denning DW.

Antimicrob Agents Chemother. 1998 Apr;42(4):873-8.

13.

Combination antifungal therapy of murine aspergillosis: liposomal amphotericin B and micafungin.

Graybill JR, Bocanegra R, Gonzalez GM, Najvar LK.

J Antimicrob Chemother. 2003 Oct;52(4):656-62. Epub 2003 Sep 12.

PMID:
12972452
14.

Pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis: evidence of concentration-dependent activity.

Wiederhold NP, Kontoyiannis DP, Chi J, Prince RA, Tam VH, Lewis RE.

J Infect Dis. 2004 Oct 15;190(8):1464-71. Epub 2004 Sep 10.

PMID:
15378439
16.

Caspofungin prolongs survival of transiently neutropenic rats with advanced-stage invasive pulmonary aspergillosis.

van de Sande WW, van Vianen W, ten Kate MT, Vissers J, Laurijsens J, Tavakol M, Rijnders BJ, Mathot RA, Bakker-Woudenberg IA.

Antimicrob Agents Chemother. 2008 Apr;52(4):1345-50. doi: 10.1128/AAC.00536-07. Epub 2008 Jan 14.

17.
18.

Treatment of murine systemic aspergillosis with polyene-intralipid admixtures.

Sionov E, Segal E.

Med Mycol. 2004 Feb;42(1):73-80.

PMID:
14982116
19.

Comparative in vivo dose-dependent activity of caspofungin and anidulafungin against echinocandin-susceptible and -resistant Aspergillus fumigatus.

Lewis RE, Liao G, Hou J, Prince RA, Kontoyiannis DP.

J Antimicrob Chemother. 2011 Jun;66(6):1324-31. doi: 10.1093/jac/dkr142. Epub 2011 Apr 11.

PMID:
21486855
20.

Anidulafungin in combination with amphotericin B against Aspergillus fumigatus.

Spreghini E, Orlando F, Santinelli A, Pisa E, Loretelli C, Manso E, Milici ME, Scalise G, Barchiesi F.

Antimicrob Agents Chemother. 2009 Sep;53(9):4035-9. doi: 10.1128/AAC.00659-09. Epub 2009 Jul 13.

Supplemental Content

Support Center